Breast Cancer
Article
Genomic Assays in HR-Positive/HER2-Negative Breast Cancer
News
Genetic counseling for cancer often costs patients nothing
Genetic counseling is an important feature of cancer care that can affect treatment decisions and surveillance. But coverage of genetic counseling...
News
FDA approves trastuzumab-deruxtecan for HER2-low breast cancer
Sixty percent of patients previously classified as having HER2-negative subtype are now considered HER2 low.
News
Node-negative triple-negative breast cancer prognosis lies within stromal lymphocytes
Every 10% increase in stromal tumor-infiltrating lymphocytes was associated with a 19% reduction in the risk of death.
News
Life and death decisions: What keeps oncologists up at night
“It’s part of the discomfort you live with as a patient and oncologist, and when I leave the clinic, that’s one thing that follows me home.”
News
Hormone therapy didn’t increase recurrence or mortality in women treated for breast cancer
Recurrence was increased with vaginal hormone therapy among those taking aromatase inhibitors.
News
Amazon involved with new cancer vaccine clinical trial
The trial is aimed at finding “personalized vaccines” to treat breast cancer and melanoma, a form of skin cancer.
Conference Coverage
Select patients with breast cancer may skip RT after lumpectomy
There is “clearly a population of early-stage breast cancer [patients] who after lumpectomy do not benefit from radiation.”
News
Study confirms BRCA1 and BRCA2 linked to seven cancers
Some associations are stronger than others with biliary tract, esophageal, and gastric cancers rising to the top.
News
Sociogenomics may explain race disparities in breast cancer mortality
Research aimed at understanding and mitigating the effects of persistent marginalization urgently needed.